Boston Scientific Corporation has announced the completion of a €1.5 billion public offering of senior notes through its wholly owned finance subsidiary, American Medical Systems Europe B.V. The company had previously announced the pricing of these senior notes on February 21, 2025.

Additionally, Boston Scientific recently reported strong financial results for the fourth quarter and full year 2024, with CEO Mike Mahoney describing it as "one of the best years in the history of the company." The company continues to expand its cardiovascular portfolio, with acquisitions such as Bolt Medical, Inc., and Intera Oncology, Inc., aimed at strengthening its interventional cardiology and oncology offerings.

Boston Scientific will also participate in TD Cowen’s 45th Annual Health Care Conference in March 2025.